Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Shares Acquired by Price T Rowe Associates Inc. MD
Price T Rowe Associates Inc. MD increased its position in Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Free Report) by 21.8% during the fourth quarter, Holdings Channel reports. The fund owned 25,641 shares of the company’s stock after purchasing an additional 4,592 shares during the quarter. Price T Rowe Associates Inc. MD’s holdings in Phathom Pharmaceuticals were […]
